the maternal and neonatal outcomes of pregnant women with definite covid-19

Background: this study aimed to assess the symptoms and clinical laboratory data of pregnant women with covid-19 in their second or third trimester of pregnancy as well as their maternal and neonatal outcomes.methods: this retrospective observational study was conducted on 177 pregnant women with covid-19 who were admitted to yas hospital (affiliated with tehran university of medical sciences), and ali-ibn-abi-talib hospital (affiliated with zahedan university of medical sciences).results: there was significant higher complaints including fever (p-value=0.015), cough (p-value=0.028), fatigue (p-value=0.002), dyspnea (p-value=0.022), and lower hemoglobin level (p-value=0.009) in patients who were in their third trimester compared to those who were in their second trimester. 9.6% (n=17) of the patients had severe disease and needed icu admission. there was a significant variation regarding gestational age (p-value=0.022) in pregnant women admitted to icu compared to the other ones. during the study, delivery happened in 108 (61%) pregnant women. fetal distress following meconium deification (p-value=0.041), need to mgso4 (p-value=0.001), iufd (p-value=0.006), need for blood transfusion (p-value=0.004), and neonatal death (p-value<0.001) were significantly higher in patients who needed icu admission.conclusion: higher gestational weeks are the main risk factor for severe covid-19 disease. although vertical transmission is rare; due to the higher risk of perinatal outcomes, the delivery should be done in a center with a nicu department.